IBM Dubbed Analyst Favorite and 4 Stock Analyses to Follow
Cree Inc. (NASDAQ:CREE): Current Price: $39.84
Stifel Nicolaus has increased its target on Cree following the company’s report of stronger Q2 results than predicted. The firm believes that the company’s margins will keep rising, and it keeps its Buy rating on the stock.
Threshold Pharmaceuticals Inc. (NASDAQ:THLD): Current Price: $5.03
Following Celgene’s (NASDAQ:CELG) reported Phase III data concerning its pancreatic cancer treatment, Stifel Nciolaus is still convinced that Threshold Pharma’s pancreatic cancer treatment will be competitive with Celgene’s product. The firm keeps its Buy rating on the stock.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.
Texas Instruments Inc. (NYSE:TXN): Current Price: $32.95
Jefferies has noted that during 2012, the company’s free cash flow of $2.9 billion was 54 percent more than net income. The firm predicts that Texas Instruments’ free cash flow will surpass its net income again in 2013, and the firm keeps its Buy rating and increases its price target on the stock.
Cardinal Health, Inc. (NYSE:CAH): Current Price: $44.53
Baird has decided to increase its price target on Cardinal Health after the company’s Q1 results due to earnings leverage, continued generics contributions, growth in platforms outside of drug distribution, and share repurchases. Baird gives the stock an Outperform rating.
International Business Machines Corp. (NYSE:IBM): Current Price: $208.57
The company has been named one of Cowen’s favorite large-cap defensive name due to IBM’s solid Q4 results, positive management commentary, margin expansion opportunities, and strong bookings at its transaction services arm. The firm gives the stock an Outperform rating.